Laurence Reid, Ph.D., is an entrepreneur, company builder, and biotech executive, leveraging his experience as an advisor to growing biotech companies. Previously, Laurence served as CEO of Decibel Therapeutics (acquired by Regeneron Pharmaceuticals) and as CEO of Warp Drive Bio (merged with Revolution Medicines). He also served as an entrepreneur in residence at Third Rock Ventures, focusing on novel drug discovery and development opportunities. Prior to that, he was Senior Vice President and Chief Business Officer at Alnylam Pharmaceuticals, where he oversaw the company’s business development, finance, and legal functions. Before joining Alnylam, Laurence held the position of Chief Business Officer at Ensemble Discovery. He spent ten years at Millennium Pharmaceuticals in various general management and business development roles. Laurence  also serves on the board of The Possible Zone, in addition to being a board advisor to Life Science Cares and Mount Auburn Hospital. He earned his Ph.D. from King’s College, London, and his B.A. from Cambridge University.